. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh: See more » AdultAnimalsAntigens, Neoplasm/analysisClinical ProtocolsGenetic TherapyHLA-A2 Antigen/analysisHistocompatibility TestingHumansImmunologic Factors/administration & dosageImmunologic Factors/geneticsImmunologic Factors/metabolismImmunologic Factors/therapeutic useImmunotherapy, Active/methodsIncidenceInformed ConsentInterleukin-2/administration & dosageInterleukin-2/geneticsInterleukin-2/metabolismInterleukin-2/therapeutic useMelanoma/epidemiologyMelanoma/immunologyMelanoma/pathologyMelanoma/therapyMelanoma, Experimental/therapyMicePilot ProjectsRecombinant Fusion Proteins/administration & dosageRecombinant Fusion Proteins/geneticsRecombinant Fusion Proteins/metabolismRecombinant Fusion Proteins/therapeutic useSafetySalvage TherapyTransduction, GeneticTransplantation, HomologousTumor Cells, Cultured/immunologyTumor Cells, Cultured/metabolismTumor Cells, Cultured/transplantation
Substances: See more » Antigens, NeoplasmHLA-A2 AntigenImmunologic FactorsInterleukin-2Recombinant Fusion Proteins
Year: 1992 PMID: 1482708 DOI: 10.1089/hum.1992.3.6-677
Source DB: PubMed Journal: Hum Gene Ther ISSN: 1043-0342 Impact factor: 5.695